The phrase "provider-reviewed" gets used loosely in online weight care — sometimes it means a genuine clinical evaluation, sometimes it means a checkbox form that a prescriber glances at for seconds. Because the difference matters enormously for your safety, it's worth understanding what real provider-reviewed care actually involves, so you can tell the two apart. This isn't about any one company. It's about the clinical standard every responsible provider should meet — and that you have every right to expect.

The core principle: the standard doesn't change because it's online

Start here, because it's the foundation. Telehealth is a legitimate way to deliver care — professional bodies like the Obesity Medicine Association publish clinical practice guidance specifically for delivering obesity care via telehealth — but the standard of care does not drop just because a visit is virtual. The consensus across clinical and regulatory bodies is consistent: a proper history must be taken, contraindications must be screened, and a real clinical judgment must be made, whether the visit happens in an office or on a screen. [1]

This matters because the category has a real enforcement history. Direct-to-consumer platforms that scaled prescribing through short visits, high prescription rates, and financial pressure on prescribers have drawn genuine scrutiny — including Department of Justice investigations and state medical board disciplinary actions against prescribers who cut those corners. The lesson for you as a patient is simple: "provider-reviewed" should mean actually reviewed, and there are markers that tell you whether it was.

What a genuine evaluation includes

A responsible provider evaluation — virtual or not — covers the same clinical ground an in-person visit would:

  • A real medical history. Not just height and weight, but your health conditions, your history, and the context a clinician needs to judge whether treatment is appropriate.- A current-medication review. GLP-1 medications interact with other drugs — including diabetes medications and, because they slow digestion, oral medications generally. A provider needs your full medication list to prescribe safely.- A contraindication screen. There are specific conditions that make these medications inappropriate — a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, certain severe gastrointestinal conditions, prior pancreatitis, among others. A provider who doesn't ask about these isn't following prescribing guidelines.- A judgment about appropriateness — including "no." This is the tell. In genuine care, completing an intake and paying for a visit does not guarantee a prescription. Medication, dose, and eligibility are decisions based on clinical judgment, your history, and applicable law. A reputable provider will either work with you to determine safety or decline to prescribe if they can't adequately assess your situation. A process that approves everyone isn't reviewing anyone.

What good follow-up looks like

Prescribing is the start of care, not the end of it. Responsible programs include structured follow-up: dose titration handled carefully (starting low and adjusting gradually, since rapid escalation drives side effects), a channel to report and manage side effects, and ongoing clinical contact rather than a fire-and-forget prescription. The relevant clinical guidelines (from bodies like the ADA and AACE) frame baseline and ongoing metabolic assessment as part of appropriate care, with the specifics depending on your individual clinical picture. [1]

The warning signs of the other kind

Because you're evaluating this for yourself, here are the markers that signal a provider prioritizing volume over care — the things a discerning patient should treat as red flags:

- High-pressure sales tactics. Countdown timers, "limited spots," "price goes up tomorrow." These are marketing techniques, not medical ones — and they have no place in a genuine clinical decision.- A form that functions as a liability waiver rather than a clinical assessment. The question is whether the intake is actually screening you, or just documenting that you clicked "no" to some risks.- No disclosed prescriber credentials. You should be able to know that a licensed clinician — and ideally one with relevant experience — is reviewing your care.- Lock-in contracts. Long minimum commitments serve the business, not your clinical needs. ## The honest note on compounded medications

One piece of context that belongs in any discussion of this category: compounded semaglutide and tirzepatide are not FDA-approved. While the branded versions of these molecules are FDA-approved for their specific indications, compounded medications are prepared by pharmacies, are not the same as the branded products, and have not undergone the same FDA review for safety and efficacy. A provider offering compounded medications should be transparent about this — it's part of informed care, not a detail to obscure.

Where care fits

Understanding the standard is what lets you hold any provider to it — including us. Cypress is built around exactly this model: a licensed provider reviews your history and your goals, screens for what needs screening, and determines whether treatment is appropriate for you — designed for the perimenopausal body specifically. If you want to see what that review involves, you can learn how provider-reviewed care works.

The right provider will welcome these questions. The care you deserve is the kind that can answer them.